News
FDA clears Moderna's mRNA-based seasonal flu shot
After a series of regulatory twists and turns, the FDA has approved Moderna's mRNA-based influenza vaccine mFlusiva.
Market Access
Why global pharmaceutical reforms are quietly redirecting ra...
Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs
News
UK postcode lottery ends for 'life-changing' cystinosis drug
Patients in England with rare disease cystinosis will soon be able to access a drug that has been available in other UK nations for up to three years
News
Are we about to see a return for the pharma mega-merger?
There are rumours that the first pharma 'mega-merger' for several years – between AstraZeneca and Bristol Myers Squibb – is under discussion.
News
Datroway joins Trodelvy for frontline TNBC in the EU
AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
